By: Sumit Jha
The oral version of the blockbuster weight-loss drug has received regulatory approval in the UK and European Union, but India's drug regulator has
Sumit Jha is an Assistant Managing Editor at The Economic Times. He specializes in health and wellness, covering a wide range of topics including consumer health, drugs and medication, maternal health, and public health. His work has been featured in notable publications such as The Economic Times, TheWire.in, and South First.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Sumit Jha's coverage is primarily focused on local government announcements and scientific topics related to health, medicine, and the pandemic. He often cites data in his articles, indicating a preference for fact-based reporting.
Given Sumit's strong focus on health-related issues such as Covid-19, medical studies, and local healthcare events in Southern India, he is likely to be interested in pitches that provide unique insights into these areas from experts based in or familiar with the region. Topics such as public health initiatives or new scientific research findings related to healthcare would also align well with his coverage.
Those who can offer data-driven analysis or commentary on government policies pertaining to healthcare within Southern India may find their pitches resonate strongly with Sumit.
This information evolves through artificial intelligence and human feedback. Improve this profile .